Nasus Pharma Ltd (NSRX): Total Liabilities

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2025-12-31 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

$2.24M
As of 2025-12-31. As filed; likely tagged in the wrong unit
$3.93M2024-12-31: $3.93M2025-12-31: $2.24M$2.24M
2024-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$2.24Mn/a2026-03-25, Balance as of period end
2024-12-31$3.93Mn/a2026-03-25, Balance as of period end